Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 787.30K | 2.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 787.30K | 2.50M |
| Cost of Revenue | 45.45M | 46.89M | 47.41M | 49.56M | 51.05M |
| Gross Profit | -45.45M | -46.89M | -47.41M | -48.77M | -48.55M |
| SG&A Expenses | 19.96M | 19.65M | 20.13M | 20.72M | 20.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.41M | 66.54M | 67.54M | 70.28M | 71.84M |
| Operating Income | -65.41M | -66.54M | -67.54M | -69.49M | -69.34M |
| Income Before Tax | -71.80M | -74.01M | -70.97M | -75.14M | -67.09M |
| Income Tax Expenses | 5.00K | 2.80K | 100.00 | 100.00 | 100.00 |
| Earnings from Continuing Operations | -71.81 | -74.01 | -70.97 | -75.14 | -67.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.81M | -74.01M | -70.97M | -75.14M | -67.09M |
| EBIT | -65.41M | -66.54M | -67.54M | -69.49M | -69.34M |
| EBITDA | -63.18M | -64.32M | -65.31M | -67.24M | -67.09M |
| EPS Basic | -1.92 | -1.99 | -1.91 | -2.09 | -1.93 |
| Normalized Basic EPS | -1.14 | -1.19 | -1.14 | -1.25 | -1.20 |
| EPS Diluted | -1.92 | -1.99 | -1.91 | -2.09 | -1.93 |
| Normalized Diluted EPS | -1.14 | -1.19 | -1.14 | -1.25 | -1.20 |
| Average Basic Shares Outstanding | 149.71M | 149.08M | 148.55M | 144.34M | 140.13M |
| Average Diluted Shares Outstanding | 149.71M | 149.08M | 148.55M | 144.34M | 140.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |